会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • METHODS OF IDENTIFYING IMMUNOREGULATORY AGENTS, IMMUNOREGULATORY AGENTS, AND USES THEREOF
    • 鉴定免疫调节剂,免疫调节剂及其用途的方法
    • WO2005063170A3
    • 2005-11-10
    • PCT/JP2004019846
    • 2004-12-28
    • TOUDAI TLO LTDMORIMOTO CHIKAOOHNUMA KEI
    • MORIMOTO CHIKAOOHNUMA KEI
    • C12N15/113G01N33/50G01N33/68G01N33/94A61K38/00C12N15/11
    • C12N15/113C12N15/1138C12N2310/14G01N33/505G01N33/9493
    • The present invention provides methods of identifying a substance that down-regulates or up-regulates an immune response and kits used for the identification methods. A method of this invention comprises detecting a substance that inhibits or enhances the interaction between CD26 and caveolin-1. Another method comprises detecting a substance that inhibits or enhances the interaction between caveolin-1 and Tollip. Still another method comprises detecting a substance that inhibits or enhances the interaction among caveolin-1, Tollip, and IRAK-1. The present invention also relates to immunoregulatory agents comprising a substance that down-regulates an immune response, such as siRNA against caveolin-1 or Tollip. The invention further provides immunoregulatory agents comprising a substance that up-regulates an immune response. These agents are useful for treating inflammatory diseases, autoimmune diseases, or other immune-mediated disorders.
    • 本发明提供了鉴定下调或上调免疫应答的物质的方法和用于鉴定方法的试剂盒。 本发明的方法包括检测抑制或增强CD26和窖蛋白-1之间相互作用的物质。 另一种方法包括检测抑制或增强窖蛋白-1与Tollip之间相互作用的物质。 另一种方法包括检测抑制或增强小窝蛋白-1,Tollip和IRAK-1之间相互作用的物质。 本发明还涉及免疫调节剂,其包含下调免疫应答的物质,例如针对小窝蛋白-1或Tollip的siRNA。 本发明进一步提供了包含上调免疫应答的物质的免疫调节剂。 这些药剂可用于治疗炎性疾病,自身免疫性疾病或其他免疫介导的疾病。
    • 3. 发明申请
    • NOVEL AROMATIC PRENYLTRANSFERASES, NUCLEIC ACIDS ENCODING SAME AND USES THEREFOR
    • 新型芳香乳酸酯,编码其的核酸及其用途
    • WO2006081537A2
    • 2006-08-03
    • PCT/US2006003161
    • 2006-01-27
    • SALK INST FOR BIOLOGICAL STUDITOUDAI TLO LTDKUZUYAMA TOMOHISANOEL JOSEPH PRICHARD STEPHANE P
    • KUZUYAMA TOMOHISANOEL JOSEPH PRICHARD STEPHANE P
    • C07H21/04
    • C12N9/1085
    • In accordance with the present invention, a novel aromatic prenyltransferase., Orf2 from Streptomyces sp. strain CL190, involved in naphterpin biosynthesis has been identified and the structure thereof elucidated. This prenyltransferase catalyzes the formation of a C-C bond between a prenyl group and a compound containing an aromatic nucleus, and also displays C-O bond formation activity. Numerous crystallographic structures of the prenyltransferase have been solved and refined, e.g., (1) prenyltransferase complexed with a buffer molecule (TAPS), (2) prenyltransferase as a binary complex with geranyl diphosphate (GPP) and Mg 2+ , and prenyltransferase as ternary complexes with a non-hydrolyzable substrate analogue, geranyl S-thiolodiphosphate (GSPP) and either (3) 1,6-dihydroxynaphthalene (1,6-DHN), or (4) flaviolin (i.e., 2,5,7-trihydroxy-1,4-naphthoquinone, which is the oxidized product of 1,3,6,8-tetrahydroxynaphthalene (THN)). These structures have been solved and refined to 1.5Å, 2.25Å, 1.95Å and 2.02Å, respectively. This first structure of an aromatic prenyltransferase displays an unexpected and non-canonical (ß/a)-barrel architecture. The complexes with both aromatic substrates and prenyl containing substrates and analogs delineate the active site and are consistent with a proposed electrophilic mechanism of prenyl group transfer. These structures also provide a mechanistic basis for understanding prenyl chain length determination and aromatic co-substrate recognition in this structurally unique family of aromatic prenyltransferases. This structural information is useful for predicting the aromatic prenyltransferase activity of proteins.
    • 根据本发明,一种新的芳族异戊烯转移酶,来自链霉菌属的Orf2。 已经鉴定了涉及萘二苯生物合成的菌株CL190,其结构被阐明。 该异戊烯基转移酶催化异戊烯基与含有芳香核的化合物之间的C-C键的形成,也显示出C-O键的形成活性。 已经解决和改进了异戊烯基转移酶的许多晶体结构,例如,(1)与缓冲分子(TAPS)络合的异戊烯基转移酶,(2)作为与香叶基二磷酸(GPP)和Mg 2+的二元复合物的异戊烯基转移酶, (3)1,6-二羟基萘(1,6-DHN),或(4)黄堇素(即2种),可以与不可水解的底物类似物,香叶基S-硫代二磷酸(GSPP)和(3) ,5,7-三羟基-1,4-萘醌,其为1,3,6,8-四羟基萘(THN)的氧化产物)。 这些结构分别被解析并精炼成1.5A,2.25,1.95和2.02。 芳族异戊烯基转移酶的这种第一结构显示出意想不到的和非规范的(ß/ a) - 桶状结构。 具有芳香底物和含异戊烯基的底物和类似物的配合物描绘了活性位点,并且与异戊烯基转移所提出的亲电子机制一致。 这些结构还提供了在这个结构独特的芳族异戊烯基转移酶家族中理解异戊烯基链长度测定和芳香族共底物识别的机理基础。 该结构信息可用于预测蛋白质的芳族异戊烯基转移酶活性。
    • 6. 发明申请
    • METHODS OF IDENTIFYING IMMUNOREGULATORY AGENTS, IMMUNOREGULATORY AGENTS, AND USES THEREOF
    • 识别免疫原性试剂,免疫检测试剂及其用途的方法
    • WO2005063170A2
    • 2005-07-14
    • PCT/JP2004/019846
    • 2004-12-28
    • TOUDAI TLO, LTD.MORIMOTO, ChikaoOHNUMA, Kei
    • MORIMOTO, ChikaoOHNUMA, Kei
    • A61K
    • C12N15/113C12N15/1138C12N2310/14G01N33/505G01N33/9493
    • The present invention provides methods of identifying a substance that down-regulates or up-regulates an immune response and kits used for the identification methods. A method of this invention comprises detecting a substance that inhibits or enhances the interaction between CD26 and caveolin-1. Another method comprises detecting a substance that inhibits or enhances the interaction between caveolin-1 and Tollip. Still another method comprises detecting a substance that inhibits or enhances the interaction among caveolin-1, Tollip, and IRAK-1. The present invention also relates to immunoregulatory agents comprising a substance that down-regulates an immune response, such as siRNA against caveolin-1 or Tollip. The invention further provides immunoregulatory agents comprising a substance that up-regulates an immune response. These agents are useful for treating inflammatory diseases, autoimmune diseases, or other immune-mediated disorders.
    • 本发明提供鉴定下调或上调免疫应答的物质的方法和用于鉴定方法的试剂盒的方法。 本发明的方法包括检测抑制或增强CD26和小窝蛋白-1之间相互作用的物质。 另一种方法包括检测抑制或增强窖1与Tollip之间相互作用的物质。 另一种方法包括检测抑制或增强窖1,Tollip和IRAK-1之间相互作用的物质。 本发明还涉及免疫调节剂,其包含下调免疫应答的物质,例如针对窖1或Tollip的siRNA。 本发明进一步提供了包含上调免疫应答的物质的免疫调节剂。 这些药剂可用于治疗炎性疾病,自身免疫疾病或其他免疫介导的疾病。